Mitchell Warren, AVAC

AVAC

Presenter Of 4 Presentations

Moderator Of 2 Sessions

Non-Commercial Satellite
Organizer
Family Planning 2020; AVAC
Room
Satellite Channel 2
Date
Sat, Jul 4, 2020
Time
06:00 AM - 07:00 AM
Session Description
Many girls and women are simultaneously at risk for unintended pregnancy, HIV, and STIs. Comprehensive sexual and reproductive health care that includes family planning (FP) and HIV services is essential to provide women with the protection they want and need. Evidence shows that integrated FP, HIV, and STI (including cervical cancer) services can improve uptake across the board and reduce stigma. The Evidence for Contraceptive Options and HIV Outcomes trial reflects the clear silos between FP and HIV/STI services, which result in funding and programmatic gaps directly affecting women and girls. The COVID-19 pandemic has only highlighted the urgency of enhanced integration. Join us as we look at what gains have been made in the year following the ECHO trial results; how COVID-19 is impacting HIV/FP services and efforts to integrate them; and what the future of integration can and should look like.
Non-Commercial Satellite
Organizer
International AIDS Society
Room
Satellite Channel 2
Date
Tue, Jul 7, 2020
Time
09:00 AM - 10:00 AM
Session Description

Biomedical prevention interventions have saved lives and helped prevent new HIV infections. However, declines in incidence remain far from UNAIDS targets. A safe and globally effective HIV vaccine remains a necessity for a durable control and end to the epidemic. Diverse and promising HIV vaccines candidates are in various stages of development and exciting results from vaccine efficacy and passive immunization trials are expected in the coming years. The vaccine field remains hopeful and determined - even with the necessary shift in attention to developing SARS-CoV-2 control measures. Communicating the wealth and breadth of ongoing research, and the steadfast commitments of funders, researchers, product developers and communities to find a vaccine remains critically important. Co-sponsored by the Enterprise, NIH/HVTN/HPTN, with the participation of the South African Medical Research Council, IAVI, EU consortiums and AVAC, this satellite will showcase current HIV vaccine research and development.

Presenter Of 2 Presentations

Bridging session

Introduction

Room
Symposia and bridging sessions On-Demand Channel
Bridging session

Optimism

Room
Symposia and bridging sessions On-Demand Channel

Moderator Of 1 Session

Bridging session
Room
Symposia and bridging sessions On-Demand Channel
Session Description
This session offers four perspectives on where we are and where we should go as we aim to end the HIV epidemic around the world. Speakers will take four distinct perspectives, each speaking across geographies and populations.

Presenter Of 2 Presentations

Bridging session

Introduction

Room
Symposia and bridging sessions On-Demand Channel
Bridging session

Optimism

Room
Symposia and bridging sessions On-Demand Channel

Moderator Of 1 Session

Bridging session
Room
Symposia and bridging sessions On-Demand Channel
Session Description
This session offers four perspectives on where we are and where we should go as we aim to end the HIV epidemic around the world. Speakers will take four distinct perspectives, each speaking across geographies and populations.

Presenter Of 6 Presentations

Bridging session

Introduction

Room
Symposia and bridging sessions On-Demand Channel
Non-Commercial Satellite

Closing remarks

Organizer
International AIDS Society
Room
Satellite Channel 2
Bridging session

Optimism

Room
Symposia and bridging sessions On-Demand Channel

Moderator Of 3 Sessions

Bridging session
Room
Symposia and bridging sessions On-Demand Channel
Session Description
This session offers four perspectives on where we are and where we should go as we aim to end the HIV epidemic around the world. Speakers will take four distinct perspectives, each speaking across geographies and populations.
Non-Commercial Satellite
Organizer
Family Planning 2020; AVAC
Room
Satellite Channel 2
Session Description
Many girls and women are simultaneously at risk for unintended pregnancy, HIV, and STIs. Comprehensive sexual and reproductive health care that includes family planning (FP) and HIV services is essential to provide women with the protection they want and need. Evidence shows that integrated FP, HIV, and STI (including cervical cancer) services can improve uptake across the board and reduce stigma. The Evidence for Contraceptive Options and HIV Outcomes trial reflects the clear silos between FP and HIV/STI services, which result in funding and programmatic gaps directly affecting women and girls. The COVID-19 pandemic has only highlighted the urgency of enhanced integration. Join us as we look at what gains have been made in the year following the ECHO trial results; how COVID-19 is impacting HIV/FP services and efforts to integrate them; and what the future of integration can and should look like.
Non-Commercial Satellite
Organizer
International AIDS Society
Room
Satellite Channel 2
Session Description

Biomedical prevention interventions have saved lives and helped prevent new HIV infections. However, declines in incidence remain far from UNAIDS targets. A safe and globally effective HIV vaccine remains a necessity for a durable control and end to the epidemic. Diverse and promising HIV vaccines candidates are in various stages of development and exciting results from vaccine efficacy and passive immunization trials are expected in the coming years. The vaccine field remains hopeful and determined - even with the necessary shift in attention to developing SARS-CoV-2 control measures. Communicating the wealth and breadth of ongoing research, and the steadfast commitments of funders, researchers, product developers and communities to find a vaccine remains critically important. Co-sponsored by the Enterprise, NIH/HVTN/HPTN, with the participation of the South African Medical Research Council, IAVI, EU consortiums and AVAC, this satellite will showcase current HIV vaccine research and development.